Regulatory
🇪🇺 EMA Page 2EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Navigate global pharma regulatory landscapes. Get critical intelligence on FDA, EMA, and global drug approval pathways for strategic decision-making.
Showing 13–24 of 38 articles
Cellectar Biosciences (CLRB) FDA Approvals, PDUFA Dates & Drug Alerts 2026
Tracy Beth Høeg's Departure: Implications for Pharma BD and Regulatory Teams
Privosegtor Secures EMA PRIME Designation for Optic Neuritis Treatment
Teva's Olan EMA Application Acceptance: Strategic Implications for Pharma
Cynata Therapeutics (ASX:CYP) Surges on European Regulatory Milestone for CYP-001
Navigating the Future of GMP: Reliance, Annex 1, and AI
Italy's Clinical Research Landscape: Strengths, Weaknesses, and Strategic Implications
ImmunityBio's Anktiva Expansion: Navigating FDA Decision Dates and Regulatory Hurdles
EMA Initiates Implementation of New EU Pharmaceutical Legislation: What Pharma Needs to Know
Merz Therapeutics and Kvvit Enter Exclusive Agreement for INBRIJA®
PRAC Meeting Highlights: Regulatory Updates from May 2026
ISCT 2026: EU Manufacturing Innovations Day 1